# To Check Comparison of Apremilast and Methotrexate Efficacy in Patients With Moderate to Severe Plaque Psoriasis Presented to Tertiary Care Hospital

> **NCT07337434** · EARLY_PHASE1 · RECRUITING · sponsor: **Syeda Sana Zaman** · enrollment: 106 (estimated)

## Conditions studied

- Chronic Plaque Psoriasis

## Interventions

- **DRUG:** Methotrexate
- **DRUG:** Apremilast

## Key facts

- **NCT ID:** NCT07337434
- **Lead sponsor:** Syeda Sana Zaman
- **Sponsor class:** OTHER_GOV
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-25
- **Primary completion:** 2026-06-25
- **Final completion:** 2026-06-25
- **Target enrollment:** 106 (ESTIMATED)
- **Last updated:** 2026-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07337434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07337434, "To Check Comparison of Apremilast and Methotrexate Efficacy in Patients With Moderate to Severe Plaque Psoriasis Presented to Tertiary Care Hospital". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07337434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*